PhRMA: Roughly 400 new meds in pipeline for infectious diseases

America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. Some of the diseases targeted plague the developing world, while others threaten lives in every country. Six medicines and five vaccines for malaria are currently in development, according to a PhRMA report. Of the 395 medicines and vaccines, 24 are on a fast track--including those for hepatitis C, severe sepsis and pneumonia. PhRMA release | Report

Suggested Articles

CureVac will spend the bulk of the proceeds on its COVID-19 vaccine, with the rest going to manufacturing, platform development and other programs.

WuXi names Dong to helm new vaccines CDMO; Paragon appoints Jimenez as capital makers lead; Levy joins Spark as CMO.

The phase 1 and 2 results suggest the vaccine may be safe, tolerable and capable of triggering production of antibodies against the coronavirus.